Etiologic factors in autoimmune hemolytic anemia.
D000373:Agglutinins; D000744:Anemia, Hemolytic, Autoimmune / Q000209:etiology*; D000818:Animals; D000917:Antibody Formation; D001323:Autoantibodies; D001666:Binding Sites, Antibody; D003080:Cold Temperature; D003587:Cytomegalovirus / Q000276:immunology; D004247:DNA / Q000096:biosynthesis; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D006649:Histocompatibility Antigens; D006801:Humans; D007108:Immune Tolerance; D007125:Immunogenetics; D007073:Immunoglobulin E; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D007244:Infectious Mononucleosis / Q000150:complications; D007938:Leukemia / Q000150:complications; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008528:Mefenamic Acid / Q000009:adverse effects; D008750:Methyldopa / Q000009:adverse effects; D051379:Mice; D008934:Mitogens; D009174:Mycoplasma / Q000276:immunology; D009175:Mycoplasma Infections / Q000150:complications; D012328:RNA Viruses / Q000276:immunology; D013587:Syphilis / Q000150:complications; D013601:T-Lymphocytes / Q000276:immunology
D000373:Agglutinins; D001323:Autoantibodies; D006649:Histocompatibility Antigens; D008934:Mitogens; D008528:Mefenamic Acid; D007073:Immunoglobulin E; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D004247:DNA